Monomethyl Fumarate
Hepatitis
Therakos LLCSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 89/ 100
Competitive context
4 Active assets in the Hepatitis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Orlistat St. Louis University | Phase 4 | BB |
URSODEOXYCHOLIC ACID West China Hospital | Phase 4 | BB |
total glucosides of paeony West China Hospital | Phase 4 | BB |
S-Adenosyl-L-Methionine US Department of Veterans Affairs | Phase 3 | B |
Telbivudine Novartis Pharmaceuticals | Phase 3 | B |
View all 22 →
Same molecule, other indications
Monomethyl Fumarate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →